Skip to main content

A Sea of Orange Hope

Image may contain: 18 people, including Lisa McCombs, people smiling, outdoor and nature

With a forecast for rain and cool temperatures, many felt the 2018 Walk for MS might be a sloppy mess; but when I arrives in Morgantown, West Virginia, I found an optimistic, celebratory atmosphere that no storm could dampen. Clouds dispersed and skies cleared, knowing that the heavens  could not compete with the storm happening on the ground at the  Waterfront.

Image may contain: outdoor

The true champions had arrived and their name was Warrior.
Image may contain: 1 person, outdoor

Image may contain: 6 people, people standing, tree and outdoorTents were erected, tables arranged, team shirt distributed, books stacked, (I got to share I Have MS. What's Your super Power? !!!!)
Image may contain: one or more people, tree, table, plant and outdoor

Image may contain: one or more people, people standing, tree and outdoor

acknowledgements made, participants in place, and the walk began,
Image may contain: 1 person, standing, tree and outdoor


with Team Tiffany in the lead. My new MS friend, Tiffany Albright, is an inspiration. she single-handedly recruited an amazing team of walkers that outnumbered any other congregation in attendance. Her numbers were amazing in monetary contributions and the enthusiasm of her teammates was more than inspiring. 

Event though I did not personally join the walkers, my day was full of amazing experiences. With my books in tow, conversations flowed easily. I spoke with newly diagnosed Taylor from neighboring Pennsylvania: Tracy, a participating Lemtrada drug rep; Crystal, diagnosed at the age of fifteen and now thirty years old; Crystal's father who insists that MS is the result of an abundance of metal infused childhood inoculations; a distinguished gentleman whose recent acquisition  of I Have MS. What's Your Super Power? has lead him to the possibility of penning his own MS journey; Sheila, whose sister in Florida lives with multiple sclerosis; MS support group leader Donna, who makes it her life purpose to learn more about our disease by sponsoring informational events around the area; guide dogs, wheelchairs, walking sticks, and smiles governed the day.

It was lovely event regardless of the tricky winds and threatening skies. 

Upon initial diagnoses, activities such as this were not highly publicized to us pleebs of MS. Of course, there probably were not many opportunities. With the advent of so many marketable MS drugs, scientific experimentation, and interest in the workings of the human immune system, I find myself immersed in a different view of my disease. 

It is exciting to be a part of the battle against the enemy and I am making the most of the information available. Join me in learning more about the MonSter. 

May3: Copaxone informational event     Thursday, May 03, 2018 Program 6:30 PM-8:30 PM Featured Speaker(s) B.K. Vaught, MD Oliverio's 52 Clay Street Morgantown, WV 26505 304-296-2565 Dinner will be provided

May 5, Stonewall Jackson Resort: WV MS Summit is coming soon. This promises to be a day full of medical and personal Warrior information, minus Big P harm input. Register now:

June 9, Holiday Inn Morgantown: Mood changes in MS

The more we know, the better we can care for ourselves.

Even though at times it feels life it, we are not alone.

Image may contain: shoes, outdoor and nature

Lisa, The Lady With the Cane


Popular posts from this blog

Alien feet?

Okay, so after my initial reunion with social media, I naively imagined today to be more productive. But, no...

For someone who doesn't spend much time perusing sites like Pinterest, my interest has suddenly piqued to the point that addiction be a possibility.

Hoping to find someone of like mind, I instead downloaded a slipper pattern I might knit for Christmas presents (oops, there goes the surprise). It looks fairly simple. Let me know if you give it a try.

And, then, I found this really neat yoga flow outlined for me.
Since yoga seems to be the go-to exercise for us Warriors, I decided to share. That way we do not have to invent our own personalized routine. You're welcome.

Then, I discovered an entire page of memes that put MS in perspective to the causal reader-reluctant  on-looker. And because  this figure is essentially in the child pose... well, you get the picture.

Of course, any information on foot drop always attracts my at…

You are invited to Letters to the MonSter

Well, the sun is shining at last and it appears that spring is sincerely here and hinting at summer weather.    That means I need a summer project; hopefully one that I can complete. With two young adult books   in various levels of completion, you will surely tells me how ridiculous I am to start yet another writing project. but, inspiration has no rules, right?
           The entire month of March MS Awareness Month led to so many
awesomeavenues of expressions, fueling my need to share and learn with 
fellow MS Warriors. So, let's hare. Let's learn. In Letters to the MonSter, 
my goal is to allow fellow Warriors to vent, scream, rant, and exorcise the  MonSter out of our lives. Let's unite in this project to erase multiple sclerosis from our lives. As Leslie Hillburn stated in the preface to my last tome to this disease, "...the ONLY place you will get any support and understanding in dealing with me (MS) is with Other People wi…

MS and children

FDA Approves First Treatment for Pediatric MS On May 11, 2018, Novartis announced that Gilenya® (fingolimod) was approved by the United States Food and Drug Administration (FDA) for the treatment of children and adolescents, ages 10 through 17, with relapsing multiple sclerosis (MS). This is the first disease-modifying therapy (DMT) to be approved for this form of the disease in this age group. Known as “pediatric MS,” nearly all of those diagnosed have the relapsing form of the disease. Children also experience approximately two-to-three times as many relapses as an individual with adult-onset MS. A clinical trial comparing Gilenya to Avonex® (interferon beta-1a) in children and adolescents found that those treated with Gilenya saw an 82-percent reduction in their annualized relapse rate over a period of up to two years. Please see MSAA's online news article, "FDA Approves Gilenya® for Pediatric MS,"for more information. If links are disabled in this email, please copy a…